ITPA genotyping test does not improve detection of Crohn's disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression

被引：63

作者：

Allorge, D

Hamdan, R

Broly, F

Libersa, C

Colombel, JF ^{[1
]}

机构：

[1] CHU Lille, Hop Huriez, Serv Hepatogastroenterol, F-59037 Lille, France

[2] Fac Med Lille, EA2679, F-59045 Lille, France

[3] CHU Lille, Hop Cardiol, Ctr Invest Clin, F-59037 Lille, France

[4] Hop St Louis, Serv Hepatogastroenterol, GETAID, Paris, France

来源：

GUT | 2005年 / 54卷 / 04期

关键词：

D O I：

10.1136/gut.2004.055947

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：565 / 565

页数：1

共 4 条

[1] Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy [J].

Colombel, JF ;

Ferrari, N ;

Debuysere, H ;

Marteau, P ;

Gendre, JP ;

Bonaz, B ;

Soulé, JC ;

Modgliani, R ;

Touze, Y ;

Catala, P ;

Libersa, C ;

Broly, F .

GASTROENTEROLOGY, 2000, 118 (06) :1025-1030

[2] TPMT in the treatment of Crohn's disease with azathioprine [J].

Lennard, L .

GUT, 2002, 51 (02) :143-146

[3] Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase) [J].

Marinaki, AM ;

Ansari, A ;

Duley, JA ;

Arenas, M ;

Sumi, S ;

Lewis, CM ;

Shobowale-Bakre, EM ;

Escuredo, E ;

Fairbanks, LD ;

Sanderson, JD .

PHARMACOGENETICS, 2004, 14 (03) :181-187

[4] Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency [J].

Sumi, S ;

Marinaki, AM ;

Arenas, M ;

Fairbanks, L ;

Shobowale-Bakre, M ;

Rees, DC ;

Thein, SL ;

Ansari, A ;

Sanderson, J ;

De Abreu, RA ;

Simmonds, HA ;

Duley, JA .

HUMAN GENETICS, 2002, 111 (4-5) :360-367

← 1 →